Bringing the fundamentals into focus…
Back to Astrana Health, Inc.
How Astrana Health, Inc. stacks up
ASTH · against 428 other Healthcare companies of similar size
Valuation
57/ 100
Above the middle of the pack.
Ranked #202 of 429 · scores higher than 52% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 50–59, including ASTH · Click a bar to see the companies
Why valuation scores 57?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 2.1% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 73% of peers. EBITDA yield: 6.3% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 80% of peers. Free cash flow yield: 4.6% vs peer median 0.0%
Metric by metric
Position: dot = ASTH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ASTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 418 reported | 2.3% | 1.7% | 53% | 30% | |
| EBITDA yieldHigher is better · 428 reported | 7.9% | 4.3% | 72% | 50% | |
| Free cash flow yieldHigher is better · 196 reported | 5.2% | -0.3% | 75% | 20% | |
| Book yieldHigher is better · 420 reported | 45.9% | 35.7% | 63% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ASTHScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score